Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis

Introduction: Despite intensive research, reliable blood-derived parameters to detect clinically significant portal hypertension (CSPH) in patients with cirrhosis are lacking. As altered homeostasis of cyclic guanosine monophosphate (cGMP), the central mediator of vasodilatation, is an essential fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturm, Lukas, Bettinger, Dominik, Roth, Lisa, Zoldan, Katharina, Stolz, Laura, Gahm, Chiara, Huber, Jan Patrick, Reincke, Marlene, Kaeser, Rafael, Boettler, Tobias, Kreisel, Wolfgang, Thimme, Robert, Schultheiss, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764357/
https://www.ncbi.nlm.nih.gov/pubmed/35059421
http://dx.doi.org/10.3389/fmed.2021.803119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764357/
https://www.ncbi.nlm.nih.gov/pubmed/35059421
http://dx.doi.org/10.3389/fmed.2021.803119

Ejemplares similares